Best of the Web
Series
Shows
Corporate Videos
Store
latest videos
Looking Forward to 2015 – Stem Cell Review (EP5)
- Introduction by Bill Kridel
- George Q. Daley, M.D., Ph.D. – Harvard Medical School, Children’s Hospital Boston
- Dr. Ronald D.G. McKay – NIH, NINDS (National Institute of Neurological Disorders and Stroke)
- Dan Marshak Ph.D. – PerkinElmer, Inc.
- Rudolf Jaenisch, M.D. – MIT (Massachusetts Institute of Technology)
- John Sinden, Ph.D. – ReNeuron Group
- Alan O. Trounson, Ph.D. – CIRM (California Institute for Regenerative Medicine)
- Alan Colman, Ph.D., M.A. – A*STAR Institute of Medical Biology, Singapore Stem Cell Consortium (SSCC)
- John Walker – iPierian
- Shinya Yamanaka, M.D., Ph.D. – UCSF and Kyoto University
- Irving L. Weissman, M.D – Stanford University
- David T. Scadden, M.D. – Harvard Medical School, Harvard Stem Cell Institute, Massachusetts General Hospital
- Gregory A. Bonfiglio – Proteus Venture Partners
- Closing Remarks by Bill Kridel
ISIS – Isis Pharma CEO Stanley Crooke Interviewed by Mark Monane
- Can ISIS Pharma’s Antisense Turn Drug Discovery on its Head?
- Genzyme and ISIS Partnership on Lead Product “Mipomersen” for LDL-Cholesterol Reduction
- ISIS Pharma’s Development Strategy, Capital Needs, and Upcoming Milestones to Look Out For
- ISIS Pharmaceuticals CEO Comments on Valuation, Plays the “Word Association” Game with Mark Monane
Lee Buckler Reports from the 2009 Phacilitate Cell & Gene Therapy Forum
1. Lee Buckler’s Cell Therapy ’08 Review and ’09 Outlook
2. Harvard Steps Into the Cell Therapy Funding Gap with a Mission for Academic Research to Get to Patients
3. Roche’s Vertes on Big Pharma’s Interest in Cell Therapy
Neural Stem Cells and CNS Disorder – Stem Cell Review (EP7)